Trilogy Global Advisors’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-490,557
Closed -$21.1M 92
2014
Q4
$21.1M Sell
490,557
-91,567
-16% -$3.72M 0.44% 67
2014
Q3
$21.5M Sell
582,124
-119,501
-17% -$4.09M 0.46% 63
2014
Q2
$22.6M Buy
701,625
+2,742
+0.4% +$84.1K 0.43% 67
2014
Q1
$20.2M Buy
698,883
+4,200
+0.6% +$128K 0.4% 74
2013
Q4
$22.7M Buy
694,683
+9,348
+1% +$298K 0.46% 68
2013
Q3
$21.3M Buy
+685,335
New +$21M 0.46% 67

Other funds holding ZTS

Trilogy Global Advisors's ZTS Position: Q1 2015 in Review

Trilogy Global Advisors sold out of Zoetis (ZTS) in Q1 2015, closing a stake of 490,557 shares — an estimated $21.1M sold.

Trilogy Global Advisors first reported a position in ZTS in Q3 2013 and held it in 6 quarters. The position peaked at $22.7M in Q4 2013. 612 funds tracked by Wall St. Rank hold ZTS as of Q1 2015.

  • Trilogy Global Advisors reported no remaining Zoetis position as of Q1 2015 after selling out during the quarter.
  • Trilogy Global Advisors sold 490,557 Zoetis shares in Q1 2015, an estimated $21.1M.
  • Trilogy Global Advisors first reported a position in Zoetis in Q3 2013 and held it in 6 quarters.
  • Trilogy Global Advisors's Zoetis position peaked at $22.7M in Q4 2013.
  • 612 funds tracked by Wall St. Rank held Zoetis as of Q1 2015.

Based on Trilogy Global Advisors's 13F filing for Q1 2015, filed 11 May 2015.